These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 19366496)

  • 81. Priority setting in Ontario's LHINs: ethics and economics in action.
    Gibson J; Mitton C; DuBois-Wing G
    Healthc Q; 2011; 14(4):35-43. PubMed ID: 22116564
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Stronger policy through evidence.
    Wright C; Levin L
    Healthc Q; 2012; 15 Spec No():70-1, 105-6. PubMed ID: 24863123
    [No Abstract]   [Full Text] [Related]  

  • 83. Public values and plurality in health priority setting: What to do when people disagree and why we should care about reasons as well as choices.
    Baker R; Mason H; McHugh N; Donaldson C
    Soc Sci Med; 2021 May; 277():113892. PubMed ID: 33882440
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Utilisation of medical technology assessment in health policy.
    van den Heuvel WJ; Wieringh R; van den Heuvel LP
    Health Policy; 1997 Dec; 42(3):211-22. PubMed ID: 10176301
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Health Impact Assessment--and beyond.
    Morrison DS; Petticrew M; Thomson H
    J Epidemiol Community Health; 2001 Apr; 55(4):219-20. PubMed ID: 11238573
    [No Abstract]   [Full Text] [Related]  

  • 86. The GRADE approach, Part 2: Evidence to decision frameworksoutlining decision-making in health.
    Quilodrán C; Kirmayr M; Valente B; Pérez-Bracchiglione J; Garegnani L; Franco JVA
    Medwave; 2021 May; 21(4):e8182. PubMed ID: 34086664
    [TBL] [Abstract][Full Text] [Related]  

  • 87. [GRADE: Evidence to Decision (EtD) frameworks - a systematic and transparent approach to making well informed healthcare choices. 1: Introduction].
    Nussbaumer-Streit B; Grillich L; Glechner A; Affengruber L; Gartlehner G; Morche J; Meerpohl JJ
    Z Evid Fortbild Qual Gesundhwes; 2018 Jul; 134():57-66. PubMed ID: 29929770
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Bringing evidence to healthcare decision making.
    Wright C; O'Rourke B
    Healthc Q; 2012; 15 Spec No():64-5, 101-4. PubMed ID: 24863121
    [No Abstract]   [Full Text] [Related]  

  • 89. GRADE EVIDENCE TO DECISION (EtD) FRAMEWORK FOR COVERAGE DECISIONS.
    Parmelli E; Amato L; Oxman AD; Alonso-Coello P; Brunetti M; Moberg J; Nonino F; Pregno S; Saitto C; Schünemann HJ; Davoli M;
    Int J Technol Assess Health Care; 2017 Jan; 33(2):176-182. PubMed ID: 28655365
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Developing recommendations for the diagnosis and treatment of Lyme disease: the role of the patient's perspective in a controversial environment.
    Pomey MP; Bush PL; Demers-Payette O; L'Espérance A; Lochhead L; Ganache I; Roy D
    Int J Technol Assess Health Care; 2020 Dec; 37():e11. PubMed ID: 33353568
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Patient engagement in health technology assessment: what constitutes 'meaningful' and how we might get there.
    Abelson J
    J Health Serv Res Policy; 2018 Apr; 23(2):69-71. PubMed ID: 29411660
    [No Abstract]   [Full Text] [Related]  

  • 92. Evidence and Value: Impact on DEcisionMaking--the EVIDEM framework and potential applications.
    Goetghebeur MM; Wagner M; Khoury H; Levitt RJ; Erickson LJ; Rindress D
    BMC Health Serv Res; 2008 Dec; 8():270. PubMed ID: 19102752
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Study types and reliability of Real World Evidence compared with experimental evidence used in Polish reimbursement decision-making processes.
    Wilk N; Wierzbicka N; Skrzekowska-Baran I; Moćko P; Tomassy J; Kloc K
    Public Health; 2017 Apr; 145():51-58. PubMed ID: 28359391
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Necessity under construction - societal weighing rationality in the appraisal of health care technologies.
    Kleinhout-Vliek T; de Bont A; Boer B
    Health Econ Policy Law; 2021 Oct; 16(4):457-472. PubMed ID: 32955010
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Evidence-based health policy: context and utilisation.
    Dobrow MJ; Goel V; Upshur RE
    Soc Sci Med; 2004 Jan; 58(1):207-17. PubMed ID: 14572932
    [TBL] [Abstract][Full Text] [Related]  

  • 96. The use and impact of rapid health technology assessments.
    Hailey D; Corabian P; Harstall C; Schneider W
    Int J Technol Assess Health Care; 2000; 16(2):651-6. PubMed ID: 10932429
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Comprehensive Drug-Class Review Framework for improved evidence-based drug policy and formulary modernization.
    Tadrous M; Knowles S; Ruddock B; Oh P; Mamdani MM; Juurlink DN; Gomes T
    Int J Technol Assess Health Care; 2020; 36(1):12-19. PubMed ID: 31796132
    [TBL] [Abstract][Full Text] [Related]  

  • 98. A framework for the systematic consideration of ethics, equity, feasibility, and acceptability in vaccine program recommendations.
    Ismail SJ; Hardy K; Tunis MC; Young K; Sicard N; Quach C
    Vaccine; 2020 Aug; 38(36):5861-5876. PubMed ID: 32532544
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Health policy directions for evidence-based decision making in Canada.
    Noseworthy T; Watanabe M
    J Eval Clin Pract; 1999 May; 5(2):227-42. PubMed ID: 10471233
    [TBL] [Abstract][Full Text] [Related]  

  • 100. The Australian government's review of positron emission tomography: evidence-based policy-making in action.
    Ware RE; Francis HW; Read KE
    Med J Aust; 2004 Jun; 180(12):627-32. PubMed ID: 15200360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.